Search hospitals > California > Orange
University of California, Irvine
Claim this profileOrange, California 92868
Global Leader in Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Alzheimer's Disease
Conducts research for Stroke
Conducts research for Multiple Sclerosis
491 reported clinical trials
87 medical researchers
Summary
University of California, Irvine is a medical facility located in Orange, California. This center is recognized for care of Cancer, Non-Small Cell Lung Cancer, Alzheimer's Disease, Stroke, Multiple Sclerosis and other specialties. University of California, Irvine is involved with conducting 491 clinical trials across 875 conditions. There are 87 research doctors associated with this hospital, such as Deepa Jeyakumar, Farshid Dayyani, Jennifer B. Valerin, and Ritesh Parajuli, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
RET
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Deepa JeyakumarUC Irvine Health/Chao Family Comprehensive Cancer Center3 years of reported clinical research
Expert in Leukemia
Expert in Acute Myeloid Leukemia
20 reported clinical trials
47 drugs studied
Farshid DayyaniUC Irvine Health/Chao Family Comprehensive Cancer Center4 years of reported clinical research
Expert in Adenocarcinoma
Studies Cancer
21 reported clinical trials
48 drugs studied
Jennifer B. ValerinUC Irvine Health/Chao Family Comprehensive Cancer Center4 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
17 reported clinical trials
32 drugs studied
Ritesh Parajuli, MDUC Irvine Health/Chao Family Comprehensive Cancer Center6 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
18 reported clinical trials
44 drugs studied
Clinical Trials running at University of California, Irvine
Bladder Cancer
Cancer
Breast Cancer
Multiple Sclerosis
Leukemia
Prostate Cancer
Lymphoid Leukemia
Overactive Bladder
Parkinson's Disease
Multiple Myeloma
CG0070
for Bladder Cancer
This is a Phase 3, open-label, single arm trial designed to evaluate Cretostimogene patients with NMIBC who have failed prior BCG therapy. Up to approximately 115 CIS bladder cancer patients with or without HG Ta or HG T1 papillary disease will be enrolled under the original protocol through Amendment 4, which will comprise Cohort C. Cohort C is closed to enrollment. Under Amendment 5-1, Cohort P was added to enroll up to 70 patients with HG Ta/T1 papillary bladder cancer. Under Amendment 6, the target number of patients enrolled in Cohort P was increased to 75. Cohort P is open to enrollment Cohort C and Cohort P will be analyzed and reported separately. Patients will have had to fail prior BCG therapy which is defined as having persistent or recurrent disease within 12 months (Cohort C) or 6 months (Cohort P) following the completion of adequate BCG therapy for HGUC
Recruiting2 awards Phase 35 criteria
TAR-200 vs Chemotherapy
for Bladder Cancer
The purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder cancer (HR-NMIBC) within 1 year of last dose of Bacillus Calmette-Guérin (BCG) therapy and who refused or are unfit for Radical Cystectomy (RC), receiving TAR-200 versus investigator's choice of single agent intravesical chemotherapy.
Recruiting2 awards Phase 32 criteria
TAR-200 + Cetrelimab vs Chemoradiotherapy
for Bladder Cancer
This trial is testing a new treatment for bladder cancer that combines a device delivering medication directly to the bladder with a drug that helps the immune system fight cancer. The goal is to see if this combination works better than the usual treatment in keeping the bladder free from cancer events.
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of California, Irvine?
University of California, Irvine is a medical facility located in Orange, California. This center is recognized for care of Cancer, Non-Small Cell Lung Cancer, Alzheimer's Disease, Stroke, Multiple Sclerosis and other specialties. University of California, Irvine is involved with conducting 491 clinical trials across 875 conditions. There are 87 research doctors associated with this hospital, such as Deepa Jeyakumar, Farshid Dayyani, Jennifer B. Valerin, and Ritesh Parajuli, MD.
Where is University of California, Irvine located?
The University of California, Irvine (UCI) Medical Center is located at 101 The City Drive South, Orange, CA 92868. For Los Angeles directions, take I-5 South to The City Drive/State College exit, right onto City Dr, straight past Chapman Ave, left onto Dawn Way with parking on the left. From San Diego, take I-5 North to Chapman Avenue/State College exit, left onto Chapman Ave, left at The City Drive, past the hospital to Dawn Way, and left again with parking on the left.
Who should I call to ask about financial aid or insurance network?
**University of California, Irvine (UCI) Hospital Financial Assistance:**
- For financial assistance, contact the UCI Student Health Center Insurance Services at 949-824-2388 or shc-insurance@uci.edu. They manage the Campus Medical Care Assistance Fund (CMCAF) for students, covering out-of-pocket medical and/or mental health expenses exceeding $500.00, up to specific out-of-pocket maximums.
**UCI Hospital Insurance Inquiries:**
- For insurance-related questions, reach out to the UC Resources team at 855-982-7284, available Monday–Friday, 8 a.m.–6 p.m. They provide support for benefits questions, provider searches, and more.
**UCI Health Care Facilitators for Retirees and Emeriti:**
- For Open Enrollment information sessions, contact the UC Retirement Administration Service Center at 1-800-888-8267. Correspondence can be sent to: UC Retirement Administration Service Center, P.O. Box 24570, Oakland, CA 94623-1570.
What insurance does University of California, Irvine accept?
UCI Health accepts a wide range of insurance plans, including PPO, HMO, and Medicare. Accepted insurance providers include Aetna, Anthem Blue Cross, Blue Shield, Cigna, Health Net, TRICARE, United Healthcare, and more. For behavioral health, UCI Health works with Anthem Behavioral Health, Cigna/Evernorth Behavioral Health, Magellan Health Services, and others. Additionally, UCI Health participates in Covered California for state-based marketplace insurance plans.
What awards or recognition has University of California, Irvine received?
University of California, Irvine (UCI) Hospital, located in Orange, California, is renowned for its excellence in heart disease and stroke treatment. It provides a wide range of resources and services to support clinical research. Among these is the Accrual and Retention Consult Service, designed to enhance participant recruitment and retention for studies.